Detalhe da pesquisa
1.
Open-Source Automated Insulin Delivery in Type 1 Diabetes.
N Engl J Med
; 387(10): 869-881, 2022 09 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36069869
2.
Glucose and Psychosocial Outcomes 12 Months Following Transition from Multiple Daily Injections to Advanced Hybrid Closed Loop in Youth with Type 1 Diabetes and Suboptimal Glycemia.
Diabetes Technol Ther
; 26(1): 40-48, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37823890
3.
Impact of Advanced Hybrid Closed Loop on Youth With High-Risk Type 1 Diabetes Using Multiple Daily Injections.
Diabetes Care
; 46(3): 628-632, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36689621
4.
Extended Use of an Open-Source Automated Insulin Delivery System in Children and Adults with Type 1 Diabetes: The 24-Week Continuation Phase Following the CREATE Randomized Controlled Trial.
Diabetes Technol Ther
; 25(4): 250-259, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36763345
5.
Improved technology satisfaction and sleep quality with Medtronic MiniMed® Advanced Hybrid Closed-Loop delivery compared to predictive low glucose suspend in people with Type 1 Diabetes in a randomized crossover trial.
Acta Diabetol
; 59(1): 31-37, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34453208
6.
Improved Glycemic Outcomes With Medtronic MiniMed Advanced Hybrid Closed-Loop Delivery: Results From a Randomized Crossover Trial Comparing Automated Insulin Delivery With Predictive Low Glucose Suspend in People With Type 1 Diabetes.
Diabetes Care
; 44(4): 969-975, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33579715
7.
HRT does not improve urinary albumin excretion in postmenopausal diabetic women.
Diabetes Res Clin Pract
; 60(1): 33-9, 2003 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-12639763